First nasal vaccine against COVID-19 developed by Bharat Biotech gets regulator nod for phase 2 trial: DBT in revised statement.

  • August 13, 2021
  • Updated: 08:43 pm
First nasal vaccine against COVID-19 developed by Bharat Biotech gets regulator nod for phase 2 trial: DBT in revised statement.